Author

Ilena Vincenti

University of GenevaORCID 0000-0003-1061-6071Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Daniel D. PinscheweriD· 2 shared Doron MerkleriD· 2 shared Ingrid WagneriD· 2 shared Anna Lena KastneriD· 1 shared Anna‐Friederike MarxiD· 1 shared Bogna KlimekiD· 1 shared Davide Finozzi· 1 shared Dominik BürriiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Daniel D. PinschewerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyMolecular Therapy — Nucleic AcidsPeer-reviewedFeb 3, 2026

Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction

Matías Ciancaglini, Robin Avanthay, Anna‐Friederike Marx…·Daniel D. Pinschewer

This paper re-engineers a cytolytic viral vector to be non-cytolytic, enhancing CD8 T cell immunity through reinforced type I IFN signaling.

1 citation

mouseexperimental assay

𝕏 PostBluesky

ImmunologyThe Journal of Experimental MedicinePeer-reviewedMar 13, 2025

Interleukin-33 from oligodendrocytes sustains effector differentiation of tissue-resident CD8+ T cells and is a druggable target in CNS autoimmune disease

Nicolas Fonta, Nicolas Pagé, Bogna Klimek…·Doron Merkler

This study identifies IL-33 from oligodendrocytes as a key regulator of self-reactive CD8+ T cell differentiation in CNS autoimmunity and shows its potential as a therapeutic target.

13 citationstop 2%

mouseproteomics

𝕏 PostBluesky